Evidence map›Paper›PMID 29874840›Full record

ReviewGenes2018

Synthesis of Biomaterials Utilizing Microfluidic Technology.

Xiaohong Wang, Jinfeng Liu, Peizhou Wang, Andrew deMello, Lingyan Feng, Xiaoli Zhu, Weijia Wen, Rimantas Kodzius, Xiuqing Gong

Abstract readReview
In one paragraph

Review in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaohong WangMaterials Genome Institute, Shanghai University, Shanghai 201800, China. wxh0201@t.shu.edu.cn.ORCID 0000-0002-3274-1925
Jinfeng LiuMaterials Genome Institute, Shanghai University, Shanghai 201800, China. Perpethere@shu.edu.cn.
Peizhou WangAdvanced Placement of Chemistry Program, International Department, Huzhou New Century Foreign Language School, Huzhou 313100, China. xiey2@uci.edu.
Andrew deMelloETH Zurich, Zurich 8093, Switzerland. andrew.demello@chem.ethz.ch.
Lingyan FengMaterials Genome Institute, Shanghai University, Shanghai 201800, China. lingyanfeng@t.shu.edu.cn.ORCID 0000-0001-9817-8680
Xiaoli ZhuSchool of Life Sciences, Shanghai University, Shanghai 200444, China. xiaolizhu@shu.edu.cn.
Weijia WenMaterials Genome Institute, Shanghai University, Shanghai 201800, China. phwen@ust.hk.
Rimantas KodziusMathematics and Natural Sciences Department, the American University of Iraq, Sulaimani, Sulaymaniyah 46001, Iraq. kodzius@envirola.com.ORCID 0000-0001-9417-8894
Xiuqing GongMaterials Genome Institute, Shanghai University, Shanghai 201800, China. rimantas.kodzius@auis.edu.krd.ORCID 0000-0001-9417-8894

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, microfluidic technologies have attracted an enormous amount of interest as potential new tools for a large range of applications including materials synthesis, chemical and biological detection, drug delivery and screening, point-of-care diagnostics, and in-the-field analysis. Their ability to handle extremely small volumes of fluids is accompanied by additional benefits, most notably, rapid and efficient mass and heat transfer. In addition, reactions performed within microfluidic systems are highly controlled, meaning that many advanced materials, with uniform and bespoke properties, can be synthesized in a direct and rapid manner. In this review, we discuss the utility of microfluidic systems in the synthesis of materials for a variety of biological applications. Such materials include microparticles or microcapsules for drug delivery, nanoscale materials for medicine or cellular assays, and micro- or nanofibers for tissue engineering.

Indexed as

artificial cellsbiomaterialsliposomesmicrofibersmicrofluidicsmicroparticlestissue engineering

Identifiers

PMID29874840
PMCPMC6027171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.